203 related articles for article (PubMed ID: 31965203)
1. [Ex vivo stem cell gene therapy of the skin : Ready for clinical use?].
Koller U
Hautarzt; 2020 Feb; 71(2):85-90. PubMed ID: 31965203
[TBL] [Abstract][Full Text] [Related]
2. Advances in gene editing strategies for epidermolysis bullosa.
Kocher T; Koller U
Prog Mol Biol Transl Sci; 2021; 182():81-109. PubMed ID: 34175052
[TBL] [Abstract][Full Text] [Related]
3. Current developments in gene therapy for epidermolysis bullosa.
Kocher T; Petkovic I; Bischof J; Koller U
Expert Opin Biol Ther; 2022 Sep; 22(9):1137-1150. PubMed ID: 35235467
[TBL] [Abstract][Full Text] [Related]
4. Advances in Gene/Cell Therapy in Epidermolysis Bullosa.
Murauer EM; Koller U; Pellegrini G; De Luca M; Bauer JW
Keio J Med; 2015; 64(2):21-5. PubMed ID: 26050701
[TBL] [Abstract][Full Text] [Related]
5. Functional therapies for cutaneous wound repair in epidermolysis bullosa.
Peking P; Koller U; Murauer EM
Adv Drug Deliv Rev; 2018 Apr; 129():330-343. PubMed ID: 29248480
[TBL] [Abstract][Full Text] [Related]
6. Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?
Tamai K; Uitto J
J Invest Dermatol; 2016 Nov; 136(11):2119-2121. PubMed ID: 27772543
[TBL] [Abstract][Full Text] [Related]
7. Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders.
March OP; Reichelt J; Koller U
Exp Physiol; 2018 Apr; 103(4):449-455. PubMed ID: 28271571
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo gene therapy cures a blistering skin disease.
Featherstone C; Uitto J
Trends Mol Med; 2007 Jun; 13(6):219-22. PubMed ID: 17416553
[TBL] [Abstract][Full Text] [Related]
9. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl S; Peking P; Kocher T; Murauer EM; Larcher F; Del Rio M; Duarte B; Steiner M; Klausegger A; Bauer JW; Reichelt J; Koller U
Mol Ther; 2017 Nov; 25(11):2573-2584. PubMed ID: 28800953
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa.
Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
Expert Opin Biol Ther; 2006 Apr; 6(4):367-78. PubMed ID: 16548763
[TBL] [Abstract][Full Text] [Related]
11. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
[TBL] [Abstract][Full Text] [Related]
12. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
[TBL] [Abstract][Full Text] [Related]
13. Towards a gene therapy clinical trial for epidermolysis bullosa.
Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
[TBL] [Abstract][Full Text] [Related]
14. Gene Replacement Therapies for Genodermatoses: A
Koller U; Bauer JW
Front Genet; 2021; 12():658295. PubMed ID: 33995490
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy approaches for epidermolysis bullosa.
Ferrari S; Pellegrini G; Mavilio F; De Luca M
Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
[TBL] [Abstract][Full Text] [Related]
16. Toward Combined Cell and Gene Therapy for Genodermatoses.
De Rosa L; Latella MC; Secone Seconetti A; Cattelani C; Bauer JW; Bondanza S; De Luca M
Cold Spring Harb Perspect Biol; 2020 May; 12(5):. PubMed ID: 31653644
[TBL] [Abstract][Full Text] [Related]
17. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.
Uitto J; Bruckner-Tuderman L; McGrath JA; Riedl R; Robinson C
J Invest Dermatol; 2018 May; 138(5):1010-1016. PubMed ID: 29391251
[TBL] [Abstract][Full Text] [Related]
18. Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses.
March OP; Kocher T; Koller U
Cells; 2020 Jan; 9(1):. PubMed ID: 31906492
[TBL] [Abstract][Full Text] [Related]
19. One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders.
Hünefeld C; Mezger M; Kern JS; Nyström A; Bruckner-Tuderman L; Müller I; Handgretinger R; Röcken M
Exp Dermatol; 2013 Mar; 22(3):162-7. PubMed ID: 23489418
[TBL] [Abstract][Full Text] [Related]
20. The genodermatoses: candidate diseases for gene therapy.
Uitto J; Pulkkinen L
Hum Gene Ther; 2000 Nov; 11(16):2267-75. PubMed ID: 11084685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
